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Alterations in Na,K-ATPase activity, in isoenzyme expression and/or number of units of the 
pump present in the plasma membrane have been associated with diabetes. These changes were 
described in different organs and tissues such as brain, heart, kidney, among others, and may 
result from altered insulin levels. However, the vast majority of studies were conducted in animal 
models of chemically induced diabetes, which are not consensual models for type 2 diabetes 
(T2D). The major goal of this work was to investigate putative modifications in Na,K-ATPase 
enzymatic activity or expression in brain, kidney, heart and liver in T2D.  
The Goto-Kakizaky rat (GK) strain was used as a model of spontaneously developed T2D, and 
Wistar rats as controls. Na,K-ATPase activity was assessed by the hydrolysis of ATP (Pi formed 
in the presence/absence of ouabain was measured using a colorimetric assay) and the 
isoenzymatic expression by Westernblot.  
A decrease in Na,K-ATPase activity in renal and cardiac tissues from GK comparatively to 
controls (55.7% and 77.5%, respectively) was observed. The pump activity was similar in liver 
and brain tissues. In renal tissue, expression of α1-Na,K-ATPase was similar between GK and 
controls but α2- was 2.3x higher and α3- was detected only in GK. Contrastingly a decreased 
expression of α1- (49.5%) and α2-isoforms (67.6%) was found in cardiac tissue. Despite similar 
Na,K-ATPase activity in liver and brain tissues, α1-isoform expression was decreased (33.9%) in 
the liver from GK while in the brain an increase of α1-isoform (~2x) together with a decrease of 
α2-isoform (14.0%) expressions were observed.  
It is unclear, except maybe for cardiac tissue where lower expression is potentially underlying 
the diminished pump activity in GK, whether the changes in isoenzyme expression is a key factor 
for differential Na,K-ATPase activity. Being responsive to complex regulation, other regulatory 
mechanisms may contribute to the impaired activity observed in kidney and heart. 
These results have uncover changes in Na,K-ATPase activity and/or enzymatic expression in GK 
brain, kidney, heart and liver that may contribute to the undesirable conditions associated with 
T2D. This work highlight the relevance of further investigation about Na,K-ATPase regulation 
and role in physiopathology of T2D. 
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Isozyme expression of isoforms α1, α2 and α3 of Na, K-ATPase were also analysed and  
changes were observed.  
In the kidney, there was an expression of 0,009±0,002 and 0,021±0,006, in control rats and 
GK, respectively, or a significant increase in expression of the α2 isoform GK. 
 
 Already in the hepatic tissue, we observed a significant decrease in expression of the α1 
isoform, registering an expression of 1,295±0,095 and 0,856±0,084, in control rats and GK, 
respectively.  
In the brain, expression of the α1 isoform in the control and GK rats was 0,367±0,021 and 
0,602±0,073, respectively, i.e. a significant increase in expression of this isoform in GK. In contrast, 
the α2 isoform, we observed a significant decrease in expression of GK, to which the recorded 
values of 0,043±0,003 and 0,037±0,001, in control rats and GK, respectively. Unlike isoform α1 and 
α2 to α3-Na, K-ATPase is not significantly different between control and GK rats for which we 
observed an expression of 0,765±0,047 and 0,684±0,044, respectively. Finally, expression of the α1 
isoform in heart and GK rats control was 0,782±0,050 and 0,465±0,054, respectively. The 
expression of the α2 isoform was 0,037±0,011 and 0,012±0,004, in control rats and GK, 
respectively. Therefore, in cardiac tissue both α1 and α2 isoform experienced a significant 
decrease in GK. 
In summary, our results point to a significant decrease in the activity of Na, K-ATPase in 
GK in renal and cardiac tissue. These changes may underlie the changes in isoenzyme expression 
also observed isoforms α1 and α2 and α3 Na, K-ATPase, which makes sodium pump an 
important therapeutic target for T2D. 
